TY - JOUR
T1 - Effect of stem cell factor on in vitro erythropoiesis in patients with bone marrow failure syndromes
AU - Alter, Blanche P.
AU - Knobloch, Mary Ellen
AU - He, Liya
AU - Gillio, Alfred P.
AU - O'Reilly, Richard J.
AU - Reilly, Laura K.
AU - Weinberg, Rona S.
PY - 1992/12/15
Y1 - 1992/12/15
N2 - Stem cell factor (SCF) enhances normal hematopoiesis. We examined its effect in vitro on bone marrow and blood progenitors from patients with inherited bone marrow failure syndromes, including 17 patients each with DiamondBlackfan anemia (DBA) and Fanconi's anemia (FA), 3 with dyskeratosis congenita (DC), and 1 each with amegakaryocytic thrombocytopenia (amega) and transient erythroblastopenia of childhood (TEC). Mononuclear cells were cultured with erythropoietin (Ep) alone or combined with SCF or other factors. SCF increased the growth of erythroid progenitors in cultures from 50% of normal controls, 90% of DBA, 70% of FA, 30% of DC, and the amega and TEC patients; normal numbers were reached in 25% of DBA studies. Improved in vitro erythropoiesis with SCF in all types of inherited marrow failure syndromes does not suggest a common defect involving kit or SCF, but implies that SCF may be helpful in the treatment of hematopoietic defects of varied etiologies.
AB - Stem cell factor (SCF) enhances normal hematopoiesis. We examined its effect in vitro on bone marrow and blood progenitors from patients with inherited bone marrow failure syndromes, including 17 patients each with DiamondBlackfan anemia (DBA) and Fanconi's anemia (FA), 3 with dyskeratosis congenita (DC), and 1 each with amegakaryocytic thrombocytopenia (amega) and transient erythroblastopenia of childhood (TEC). Mononuclear cells were cultured with erythropoietin (Ep) alone or combined with SCF or other factors. SCF increased the growth of erythroid progenitors in cultures from 50% of normal controls, 90% of DBA, 70% of FA, 30% of DC, and the amega and TEC patients; normal numbers were reached in 25% of DBA studies. Improved in vitro erythropoiesis with SCF in all types of inherited marrow failure syndromes does not suggest a common defect involving kit or SCF, but implies that SCF may be helpful in the treatment of hematopoietic defects of varied etiologies.
UR - http://www.scopus.com/inward/record.url?scp=0027051304&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027051304&partnerID=8YFLogxK
M3 - Article
C2 - 1281683
AN - SCOPUS:0027051304
SN - 0006-4971
VL - 80
SP - 3000
EP - 3008
JO - Blood
JF - Blood
IS - 12
ER -